Biological Intellectual Property Protection Act of 2025

This bill restricts the export of U.S. intellectual property and sensitive information related to synthetic biology to foreign entities of concern. It adds a new license requirement for exporting digital sequences of synthetic DNA or RNA to such entities, with a limited exception for certain publicly available information.

Sec. 3, License requirement to protect U.S. intellectual property and sensitive information related to synthetic biology: Within one year of enactment, the Secretary must require a license for exporting, reexporting, or in-country transferring a digital sequence of synthetic DNA or RNA designed by humans or AI to a foreign entity of concern. This does not apply to information already exempt under existing Export Administration Regulations. The section defines key terms: 'digital sequence' as a binary file representing DNA or RNA molecule symbols; 'foreign country of concern' as defined in another law; 'foreign entity of concern' as a government entity of such a country, a foreign person under its jurisdiction, or one owned or controlled by such entities; and 'synthetic DNA or RNA' as constructed or synthesized nucleic acid molecules that can replicate or base pair with natural ones.